Sol-Gel Technologies (SLGL) Competitors $7.26 +0.25 (+3.50%) Closing price 07/9/2025 02:38 PM EasternExtended Trading$7.33 +0.08 (+1.03%) As of 07/9/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SLGL vs. CHEK, DRCT, FBRX, CLLS, CLYM, CABA, MCRB, TCRX, VNRX, and SRZNShould you be buying Sol-Gel Technologies stock or one of its competitors? The main competitors of Sol-Gel Technologies include Check-Cap (CHEK), Direct Digital (DRCT), Forte Biosciences (FBRX), Cellectis (CLLS), Climb Bio (CLYM), Cabaletta Bio (CABA), Seres Therapeutics (MCRB), TScan Therapeutics (TCRX), VolitionRx (VNRX), and Surrozen (SRZN). Sol-Gel Technologies vs. Its Competitors Check-Cap Direct Digital Forte Biosciences Cellectis Climb Bio Cabaletta Bio Seres Therapeutics TScan Therapeutics VolitionRx Surrozen Check-Cap (NASDAQ:CHEK) and Sol-Gel Technologies (NASDAQ:SLGL) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations, institutional ownership and media sentiment. Is CHEK or SLGL more profitable? Check-Cap has a net margin of 0.00% compared to Sol-Gel Technologies' net margin of -107.78%. Check-Cap's return on equity of 0.00% beat Sol-Gel Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Check-CapN/A N/A N/A Sol-Gel Technologies -107.78%-43.98%-35.28% Do analysts recommend CHEK or SLGL? Sol-Gel Technologies has a consensus price target of $40.00, indicating a potential upside of 451.34%. Given Sol-Gel Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Sol-Gel Technologies is more favorable than Check-Cap.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Check-Cap 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Sol-Gel Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals believe in CHEK or SLGL? 1.1% of Check-Cap shares are owned by institutional investors. Comparatively, 26.2% of Sol-Gel Technologies shares are owned by institutional investors. 0.5% of Check-Cap shares are owned by company insiders. Comparatively, 66.5% of Sol-Gel Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has better earnings & valuation, CHEK or SLGL? Sol-Gel Technologies has higher revenue and earnings than Check-Cap. Sol-Gel Technologies is trading at a lower price-to-earnings ratio than Check-Cap, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCheck-CapN/AN/A-$17.57M-$3.00-0.27Sol-Gel Technologies$11.54M1.75-$10.58M-$4.70-1.54 Does the media prefer CHEK or SLGL? In the previous week, Check-Cap had 1 more articles in the media than Sol-Gel Technologies. MarketBeat recorded 2 mentions for Check-Cap and 1 mentions for Sol-Gel Technologies. Check-Cap's average media sentiment score of 0.00 equaled Sol-Gel Technologies'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Check-Cap 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Sol-Gel Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, CHEK or SLGL? Check-Cap has a beta of 0.19, indicating that its stock price is 81% less volatile than the S&P 500. Comparatively, Sol-Gel Technologies has a beta of 1.09, indicating that its stock price is 9% more volatile than the S&P 500. SummarySol-Gel Technologies beats Check-Cap on 8 of the 14 factors compared between the two stocks. Get Sol-Gel Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SLGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SLGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SLGL vs. The Competition Export to ExcelMetricSol-Gel TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$19.53M$3.85B$5.51B$8.95BDividend YieldN/A1.17%5.25%4.04%P/E Ratio-1.547.4928.0220.16Price / Sales1.7515.28410.25174.36Price / CashN/A6.4837.0657.97Price / Book0.702.828.145.62Net Income-$10.58M-$109.62M$3.16B$248.50M7 Day Performance-1.83%12.93%3.13%4.49%1 Month Performance4.99%16.79%3.47%7.03%1 Year Performance-15.32%32.12%34.20%21.07% Sol-Gel Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SLGLSol-Gel Technologies2.0882 of 5 stars$7.26+3.5%$40.00+451.3%-24.4%$19.53M$11.54M-1.5450News CoverageGap UpCHEKCheck-Cap0.4502 of 5 stars$0.77+0.7%N/A-58.9%$4.48MN/A-0.2680DRCTDirect Digital3.4951 of 5 stars$0.57+4.6%$6.00+961.9%-84.2%$10.21M$62.29M-0.3260Gap DownFBRXForte Biosciences2.5529 of 5 stars$12.93+5.6%$61.00+371.8%+59,900.0%$80.65MN/A-0.795Options VolumeGap DownCLLSCellectis2.8898 of 5 stars$1.53+5.2%$4.00+162.3%-15.1%$80.60M$49.22M-1.77290CLYMClimb Bio2.6328 of 5 stars$1.24+5.1%$9.00+625.8%N/A$79.74MN/A-0.529Positive NewsCABACabaletta Bio1.5254 of 5 stars$1.52-3.2%$14.43+849.2%-78.0%$79.67MN/A-0.6050Positive NewsGap UpMCRBSeres Therapeutics3.5638 of 5 stars$11.11+22.1%$73.67+563.1%-39.3%$79.46M$126.32M-2.42330Positive NewsHigh Trading VolumeTCRXTScan Therapeutics2.5897 of 5 stars$1.45+3.6%$7.80+437.9%-68.9%$79.23M$2.82M-1.33100News CoverageVNRXVolitionRx2.2938 of 5 stars$0.76-9.3%$3.50+360.5%+7.0%$78.30M$1.31M-2.1180News CoverageAnalyst ForecastGap UpSRZNSurrozen2.7713 of 5 stars$8.94-0.9%$38.50+330.6%-17.0%$77.24M$10.65M-0.3680Positive NewsHigh Trading Volume Related Companies and Tools Related Companies Check-Cap Alternatives Direct Digital Alternatives Forte Biosciences Alternatives Cellectis Alternatives Climb Bio Alternatives Cabaletta Bio Alternatives Seres Therapeutics Alternatives TScan Therapeutics Alternatives VolitionRx Alternatives Surrozen Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SLGL) was last updated on 7/10/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredHow a Kansas farm boy gained 1,285% in two daysA former farm kid placed a simple trade… and cashed out a 1,285% gain two days later. It wasn’t crypto or a...TradeSmith | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting—or plan to collect—Social Security, this could be a game-changer. A new initiative tie...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sol-Gel Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sol-Gel Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.